Dr. Chakrabarti earned his PhD from the City University of New York. He conducted postdoctoral training at University of Rochester, New York; the Institute of Theoretical Science in Eugene, Oregon; and the University of Bielefeld, Germany. Currently he is a Senior Lecturer at the Indian Association for the Cultivation of Science (IACS) in Kolkata, India and a Principle Investigator at Gyanxet-Beta, a commercial lab which develops tools and resources for RNA bioinformatics. Dr. Chakrabarti’s research areas include the role of noncoding RNAs in human disease, specifically in viral infections and head and neck cancer, as well as stem cells and pluripotency and the development of bioinformatics tools for analyzing noncoding RNAs. He has more than fifteen years of research experience in epigenetics, focusing on noncoding RNAs, and more than twenty-five years teaching experience at IACS. In addition to his teaching and research, Dr. Chakrabarti has published more than fifty scientific papers in peer reviewed journals and has served on the editorial boards of Scientific Reports, Bioinformatics, Journal of Biomolecular Structure and Dynamics, Nucleic Acids Research, DNA Research, Human Mutations, PLOS Computational Biology, and BMC Genomics. His lab at IACS has collaborated on epigenetic research with labs at the Massachusetts Institute of Technology, University of Georgia, Stanford University, and the University of Bielefeld, among others. Since 2010 Sanga Mitra has served as a Senior Research Fellow at the Indian Association for the Cultivation of Science (IACS) in Kolkata, India, under the mentorship of her PhD advisor, Jayprokas Chakrabarti. Her research areas within the Computational Biology group at IACS include microarray and RNA-Sequencing data analysis, histone modifications, head and neck cancer, and tRNA gene annotation. She holds an M.S. in Bioinformatics and has recently submitted her PhD dissertation, “Computational Genomics and miRNomics of Cancer.” Sanga Mitra has also presented on her research at genomics, cancer, and bioinformatics conferences around the world, most notably at BIT’s 3rd World DNA and Genome Day, New Horizons in Cancer Research, and the International Conference on Stem Cells and Cancer. She has published eight scientific papers to-date in peer reviewed journals including RNA and Transcription, Journal of Biomolecular Structure and Dynamics, Scientific Reports, Genomic Medicine, and Cancer Biomarkers. Dr. Tollefsbol is a Distinguished Professor of Biology and a Senior Scientist in the O’Neal Comprehensive Cancer Center, Integrative Center for Aging Research, Nutrition Obesity Research Center, University Wide Microbiome Center, and the Comprehensive Diabetes Center at the University of Alabama at Birmingham (UAB). He is Director of the UAB Cell Senescence Culture Facility which he established in 1999. Dr. Tollefsbol trained as a Postdoctoral Fellow and Assistant Research Professor with members of the National Academy of Science at Duke University and the University of North Carolina. He earned doctorates in molecular biology and osteopathic medicine from the University of North Texas Health Sciences Center and his bachelor’s degree in Biology from the University of Houston. He has received prior funding from the NCI, NHLBI, NIMH and other federal institutes as well as the Glenn Foundation for Medical Research, Susan G. Komen for the Cure, the American Federation for Aging Research (AFAR), and the American Institute for Cancer Research (AICR) among many other sources.

• 1. IntroductionSECTION I: NON-CODING RNAs: FINE-TUNING CANCER2. miRNA and Cancer: A Deadly Liaison?3. Alteration of MicroRNA Biogenesis Pathways in Cancers4. MicroRNAs In Exosomes in Cancer5. Circulating miRNAs Incresaing the Risk of Cancer6.  Long Noncoding RNAs as Cancer Biomarkers7. The Balancing Act: Understanding MicroRNA and Competing Endogenous RNA Regulation in Cancer8. PIWI-Interacting RNAs (piRNAs) and Cancer9. Transfer RNA in Cancer10. Dynamic Regulation of tRNA Modifications in Cancer11. Circular RNA: A Novel Noncoding RNA in Cancer12. Antisense RNA and Cancer13. Implication of Other Noncoding RNAs in CancerSECTION 2: GENETIC DYSREGULATION OF NON-CODING RNA IN CANCER14. Noncoding RNA Alterations in Cancer Molecular Pathways15. Genetic Alteration of MicroRNA Affecting Cancer Pathways16. Genetic Variations of Long Noncoding RNAs in CancerSECTION 3: EPIGENETIC EFFECT ON CANCER THROUGH NON-CODING RNAs17. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer18. Noncoding RNAs Act as a Chromatin Scaffold of Histone Modification Complexes in Cancer19. Heterochromatin Modulation and PcG Control of Gene Expression Medicated by Noncoding RNA in Cancer20. Epigenetic Control of MicroRNA Expression and Cancer21. Implications of Long Noncoding RNAs in Cancer EpigeneticsSECTION 4: THERAPEUTIC IMPLICATIONS OF NON-CODING RNA IN CANCER22. Long Noncoding RNAs: Insight Into Their Roles in Normal and Cancer Stem Cells23. Clinical Relevance, Prognostic Potential, and Therapeutic Strategies of Noncoding RNAs in Cancer24. Noncoding RNAs: Novel Targets in Anticancer Drug DevelopmentSECTION 5: BIOINFORMATICS' DETECTION OF NON-CODING RNA IN CANCER25. Cancer Noncoding RNA Discovery Through High-Throughput Sequencing26. Noncoding RNAs as a Cauce of Cancer: Evidence From Genome-Wide Association Studies and Reverse Genetics27. A Comparative Evaluation of Emerging Databases and Tools for Cancer Noncoding RNAs28. Future Directions and Challenges Involved in Cancer Noncoding RNomics

Dr. Chakrabarti earned his PhD from the City University of New York. He conducted postdoctoral training at University of Rochester, New York; the Institute of Theoretical Science in Eugene, Oregon; and the University of Bielefeld, Germany. Currently he is a Senior Lecturer at the Indian Association for the Cultivation of Science (IACS) in Kolkata, India and a Principle Investigator at Gyanxet-Beta, a commercial lab which develops tools and resources for RNA bioinformatics. Dr. Chakrabarti’s research areas include the role of noncoding RNAs in human disease, specifically in viral infections and head and neck cancer, as well as stem cells and pluripotency and the development of bioinformatics tools for analyzing noncoding RNAs. He has more than fifteen years of research experience in epigenetics, focusing on noncoding RNAs, and more than twenty-five years teaching experience at IACS. In addition to his teaching and research, Dr. Chakrabarti has published more than fifty scientific papers in peer reviewed journals and has served on the editorial boards of Scientific Reports, Bioinformatics, Journal of Biomolecular Structure and Dynamics, Nucleic Acids Research, DNA Research, Human Mutations, PLOS Computational Biology, and BMC Genomics. His lab at IACS has collaborated on epigenetic research with labs at the Massachusetts Institute of Technology, University of Georgia, Stanford University, and the University of Bielefeld, among others. Since 2010 Sanga Mitra has served as a Senior Research Fellow at the Indian Association for the Cultivation of Science (IACS) in Kolkata, India, under the mentorship of her PhD advisor, Jayprokas Chakrabarti. Her research areas within the Computational Biology group at IACS include microarray and RNA-Sequencing data analysis, histone modifications, head and neck cancer, and tRNA gene annotation. She holds an M.S. in Bioinformatics and has recently submitted her PhD dissertation, “Computational Genomics and miRNomics of Cancer.” Sanga Mitra has also presented on her research at genomics, cancer, and bioinformatics conferences around the world, most notably at BIT’s 3rd World DNA and Genome Day, New Horizons in Cancer Research, and the International Conference on Stem Cells and Cancer. She has published eight scientific papers to-date in peer reviewed journals including RNA and Transcription, Journal of Biomolecular Structure and Dynamics, Scientific Reports, Genomic Medicine, and Cancer Biomarkers. Dr. Tollefsbol is a Distinguished Professor of Biology and a Senior Scientist in the O’Neal Comprehensive Cancer Center, Integrative Center for Aging Research, Nutrition Obesity Research Center, University Wide Microbiome Center, and the Comprehensive Diabetes Center at the University of Alabama at Birmingham (UAB). He is Director of the UAB Cell Senescence Culture Facility which he established in 1999. Dr. Tollefsbol trained as a Postdoctoral Fellow and Assistant Research Professor with members of the National Academy of Science at Duke University and the University of North Carolina. He earned doctorates in molecular biology and osteopathic medicine from the University of North Texas Health Sciences Center and his bachelor’s degree in Biology from the University of Houston. He has received prior funding from the NCI, NHLBI, NIMH and other federal institutes as well as the Glenn Foundation for Medical Research, Susan G. Komen for the Cure, the American Federation for Aging Research (AFAR), and the American Institute for Cancer Research (AICR) among many other sources.

• 1. IntroductionSECTION I: NON-CODING RNAs: FINE-TUNING CANCER2. miRNA and Cancer: A Deadly Liaison?3. Alteration of MicroRNA Biogenesis Pathways in Cancers4. MicroRNAs In Exosomes in Cancer5. Circulating miRNAs Incresaing the Risk of Cancer6.  Long Noncoding RNAs as Cancer Biomarkers7. The Balancing Act: Understanding MicroRNA and Competing Endogenous RNA Regulation in Cancer8. PIWI-Interacting RNAs (piRNAs) and Cancer9. Transfer RNA in Cancer10. Dynamic Regulation of tRNA Modifications in Cancer11. Circular RNA: A Novel Noncoding RNA in Cancer12. Antisense RNA and Cancer13. Implication of Other Noncoding RNAs in CancerSECTION 2: GENETIC DYSREGULATION OF NON-CODING RNA IN CANCER14. Noncoding RNA Alterations in Cancer Molecular Pathways15. Genetic Alteration of MicroRNA Affecting Cancer Pathways16. Genetic Variations of Long Noncoding RNAs in CancerSECTION 3: EPIGENETIC EFFECT ON CANCER THROUGH NON-CODING RNAs17. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer18. Noncoding RNAs Act as a Chromatin Scaffold of Histone Modification Complexes in Cancer19. Heterochromatin Modulation and PcG Control of Gene Expression Medicated by Noncoding RNA in Cancer20. Epigenetic Control of MicroRNA Expression and Cancer21. Implications of Long Noncoding RNAs in Cancer EpigeneticsSECTION 4: THERAPEUTIC IMPLICATIONS OF NON-CODING RNA IN CANCER22. Long Noncoding RNAs: Insight Into Their Roles in Normal and Cancer Stem Cells23. Clinical Relevance, Prognostic Potential, and Therapeutic Strategies of Noncoding RNAs in Cancer24. Noncoding RNAs: Novel Targets in Anticancer Drug DevelopmentSECTION 5: BIOINFORMATICS' DETECTION OF NON-CODING RNA IN CANCER25. Cancer Noncoding RNA Discovery Through High-Throughput Sequencing26. Noncoding RNAs as a Cauce of Cancer: Evidence From Genome-Wide Association Studies and Reverse Genetics27. A Comparative Evaluation of Emerging Databases and Tools for Cancer Noncoding RNAs28. Future Directions and Challenges Involved in Cancer Noncoding RNomics

Dr. Chakrabarti earned his PhD from the City University of New York. He conducted postdoctoral training at University of Rochester, New York; the Institute of Theoretical Science in Eugene, Oregon; and the University of Bielefeld, Germany. Currently he is a Senior Lecturer at the Indian Association for the Cultivation of Science (IACS) in Kolkata, India and a Principle Investigator at Gyanxet-Beta, a commercial lab which develops tools and resources for RNA bioinformatics. Dr. Chakrabarti’s research areas include the role of noncoding RNAs in human disease, specifically in viral infections and head and neck cancer, as well as stem cells and pluripotency and the development of bioinformatics tools for analyzing noncoding RNAs. He has more than fifteen years of research experience in epigenetics, focusing on noncoding RNAs, and more than twenty-five years teaching experience at IACS. In addition to his teaching and research, Dr. Chakrabarti has published more than fifty scientific papers in peer reviewed journals and has served on the editorial boards of Scientific Reports, Bioinformatics, Journal of Biomolecular Structure and Dynamics, Nucleic Acids Research, DNA Research, Human Mutations, PLOS Computational Biology, and BMC Genomics. His lab at IACS has collaborated on epigenetic research with labs at the Massachusetts Institute of Technology, University of Georgia, Stanford University, and the University of Bielefeld, among others. Since 2010 Sanga Mitra has served as a Senior Research Fellow at the Indian Association for the Cultivation of Science (IACS) in Kolkata, India, under the mentorship of her PhD advisor, Jayprokas Chakrabarti. Her research areas within the Computational Biology group at IACS include microarray and RNA-Sequencing data analysis, histone modifications, head and neck cancer, and tRNA gene annotation. She holds an M.S. in Bioinformatics and has recently submitted her PhD dissertation, “Computational Genomics and miRNomics of Cancer.” Sanga Mitra has also presented on her research at genomics, cancer, and bioinformatics conferences around the world, most notably at BIT’s 3rd World DNA and Genome Day, New Horizons in Cancer Research, and the International Conference on Stem Cells and Cancer. She has published eight scientific papers to-date in peer reviewed journals including RNA and Transcription, Journal of Biomolecular Structure and Dynamics, Scientific Reports, Genomic Medicine, and Cancer Biomarkers. Dr. Tollefsbol is a Distinguished Professor of Biology and a Senior Scientist in the O’Neal Comprehensive Cancer Center, Integrative Center for Aging Research, Nutrition Obesity Research Center, University Wide Microbiome Center, and the Comprehensive Diabetes Center at the University of Alabama at Birmingham (UAB). He is Director of the UAB Cell Senescence Culture Facility which he established in 1999. Dr. Tollefsbol trained as a Postdoctoral Fellow and Assistant Research Professor with members of the National Academy of Science at Duke University and the University of North Carolina. He earned doctorates in molecular biology and osteopathic medicine from the University of North Texas Health Sciences Center and his bachelor’s degree in Biology from the University of Houston. He has received prior funding from the NCI, NHLBI, NIMH and other federal institutes as well as the Glenn Foundation for Medical Research, Susan G. Komen for the Cure, the American Federation for Aging Research (AFAR), and the American Institute for Cancer Research (AICR) among many other sources.

• 1. IntroductionSECTION I: NON-CODING RNAs: FINE-TUNING CANCER2. miRNA and Cancer: A Deadly Liaison?3. Alteration of MicroRNA Biogenesis Pathways in Cancers4. MicroRNAs In Exosomes in Cancer5. Circulating miRNAs Incresaing the Risk of Cancer6.  Long Noncoding RNAs as Cancer Biomarkers7. The Balancing Act: Understanding MicroRNA and Competing Endogenous RNA Regulation in Cancer8. PIWI-Interacting RNAs (piRNAs) and Cancer9. Transfer RNA in Cancer10. Dynamic Regulation of tRNA Modifications in Cancer11. Circular RNA: A Novel Noncoding RNA in Cancer12. Antisense RNA and Cancer13. Implication of Other Noncoding RNAs in CancerSECTION 2: GENETIC DYSREGULATION OF NON-CODING RNA IN CANCER14. Noncoding RNA Alterations in Cancer Molecular Pathways15. Genetic Alteration of MicroRNA Affecting Cancer Pathways16. Genetic Variations of Long Noncoding RNAs in CancerSECTION 3: EPIGENETIC EFFECT ON CANCER THROUGH NON-CODING RNAs17. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer18. Noncoding RNAs Act as a Chromatin Scaffold of Histone Modification Complexes in Cancer19. Heterochromatin Modulation and PcG Control of Gene Expression Medicated by Noncoding RNA in Cancer20. Epigenetic Control of MicroRNA Expression and Cancer21. Implications of Long Noncoding RNAs in Cancer EpigeneticsSECTION 4: THERAPEUTIC IMPLICATIONS OF NON-CODING RNA IN CANCER22. Long Noncoding RNAs: Insight Into Their Roles in Normal and Cancer Stem Cells23. Clinical Relevance, Prognostic Potential, and Therapeutic Strategies of Noncoding RNAs in Cancer24. Noncoding RNAs: Novel Targets in Anticancer Drug DevelopmentSECTION 5: BIOINFORMATICS' DETECTION OF NON-CODING RNA IN CANCER25. Cancer Noncoding RNA Discovery Through High-Throughput Sequencing26. Noncoding RNAs as a Cauce of Cancer: Evidence From Genome-Wide Association Studies and Reverse Genetics27. A Comparative Evaluation of Emerging Databases and Tools for Cancer Noncoding RNAs28. Future Directions and Challenges Involved in Cancer Noncoding RNomics